Main Menu

Publications

 

  1. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL; The UK Genetic Prostate Cancer Study Collaborators; British Association of Urological Surgeons' Section of Oncology; The UK ProtecT Study Collaborators, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF. Multiple newly identified loci associated with prostate cancer susceptibility. Nature Genetics. 2008; 40(3):316-321. PMID: 18264097.

     

  2. Ghoussaini M, Song H, Koessler T, Al Olama AA,Kote-Jarai Z, Driver, KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, Edwards SM, Morrison J, Donovan JL, Hamdy FC, Dearnaley DP, Arden-Jones AT, Hall AL, O’Brien LT, Gehr-Swain BN, Wilkinson RA, Brown, PM, Hopper JL, Neal DE, Pharoah PDP, Ponder BAJ, Eeles RA, Easton DF, Dunning AM; for the UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Sections of Oncology and the UK ProtecT Study Collaborators. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst. 2008; 100(13): 962-966. PMID: 18577746.

     

  3. Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, Schaid D, Thibodeau S, Dork T, Neal D, Cox A, Maier C, Vogel W, Guy M, Muir K, Lophatananon A, Kedda MA, Spurdle A, Steginga S, John EM, Giles G, Hopper J, Chappuis PO, Hutter P, Foulkes WD, Hamel N, Salinas CA, Koopmeiners JS, Karyadi DM, Johanneson B, Wahlfors T, Tammela TL, Stern MC, Corral R, McDonnell SK, Schurmann P, Meyer A, Kuefer R, Leongamornlert DA, Tymrakiewicz M, Liu JF, O’Mara T, Gardiner RA, Aitken J, Joshi AD, Severi G, English DR, Southey M, Edwards SM, Al Olama AA; PRACTICAL Consortium, Eeles RA. Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev. 2008; 17(8):2052-61. PMID: 18708398.

     

  4. Kote-Jarai Z, Jugurnauth S, Mulholland S, Leongamornlert DA, Guy M, Edwards S, Tymrakiewicz M, O’Brien L, Hall A, Wilkinson R, Al Olama AA, Morrison J, Muir K, Neal D, Donovan J, Hamdy F, Easton DF, The UKGPCS Collaborators, The British Association of Urological Surgeons’ Section of Oncology, Eeles R. A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer. British Journal of Cancer 2009; 100(2):426-30. PMID: 19127258.

     

  5. Dimitropoulou P, Lophatananon A, Easton D, Pocock R, Dearnaley DP, Guy M, Edwards S, O'Brien L, Hall A, Wilkinson R, UK Genetic Prostate Cancer Study Collaborators; British Association of Urological Surgeons Section of Oncology, Eeles R*, Muir KR*. *joint last authors. Sexual activity and prostate cancer risk in men diagnosed at a younger age. BJU Intl 2009; 103(2):178-85.PMID: 19016689.

     

  6. Eeles RA, Kote-Jarai Z, Al-OlamaAA, Giles G, Guy M,Severi, G,Muir K, Hopper JL, HendersonBE,Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL,Stanford JL, Ostrander E, Ingles S, John EM,Thibodeau SN, Schaid D, Park J, Spurdle A,Clements J, Dickinson JL,Maier C, Vogel W,Dörk T,Rebbeck TR,Cooney KA,Cannon-Albright L,Chappuis PO, Hutter P, Zeegers M, Kaneva R, Zhang H-W, Lu Y-J, Foulkes WD,English DR, Leongamornlert DA, Tymrakiewicz M, Morrison J, Ardern-Jones AT, Hall AL, O’Brien LT, Wilkinson RA,Saunders EJ, Page EC,Sawyer EJ, Edwards SM, Dearnaley DP, Horwich A, Huddart R, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A,Christmas T, Ogden C, Cooper CS, Southey MC,Lophatananon A, Liu J-F,Kolonel LN,Le Marchand L, Wahlfors T,Tammela TL, Auvinen A,Lewis SJ,Cox A, FitzGerald LM, Koopmeiners JS,Karyadi DM, Kwon EM, Stern MC,Corral R, Joshi AD, Shahabi A, McDonnell SK,Chambers S, Aitken J, Gardiner RA,Batra J,Kedda MA, Lose F,Polanowski A, Patterson B, Serth J,Meyer A, Luedeke M, Stefflova K, Ray AM,Lange EM, Farnham J,Khan H, Slavov C, Mitkova A,Cao G, The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology, The UK ProtecT Study Collaborators, The PRACTICAL Consortium, Easton DF. Identification of seven novel prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics. 2009;41(10):1116-21. PMID: 19767753.

     

  7. Collin SM, Metcalfe C, Zuccolo L, Lewis SJ, Chen L, Cox A, Davis M, Lane JA, Donovan J, Smith GD, Neal DE, Hamdy FC, Gudmundsson J, Sulem P, Rafnar T, Benediktsdottir KR, Eeles RA, Guy M, Kote-Jarai Z; UK Genetic Prostate Cancer Study Group, Morrison J, Al Olama AA, Stefansson K, Easton DF, Martin RM. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: A population-based nested case-control study, systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2009; 18(9): 2528-39. PMID: 19706844.

     

  8. Al Olama AA Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, Leongamornlert DA, Tymrakiewicz M, Saunders E, Hopper JL, Southey MC, Muir KR, English DR, Dearnaley DP, Ardern-Jones AT, Hall AL, O’Brien LT, Wilkinson RA,Sawyer E, Lophatananon A, The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology, The UK ProtecT Study Collaborators, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper C, Donovan JL, Hamdy FC, Neal DE, Eeles R*, Easton DF* Multiple loci on 8q24 associated with prostate cancer susceptibility. * Equal contribution. Nature Genetics. 2009; 41(10): 1058-60. PMID: 19767752.

     

  9. Kote-Jarai Z, Leongamornlert D, Tymrakiewicz M, Field H, Guy M, Al Olama AA, Morrison J, O’Brien L, Wilkinson R, Hall A, Sawyer E, Muir K, Hamdy F, Donovan J, Neal D, Easton D, Eeles R. Mutation analysis of the MSMB gene in familial prostate cancer. British Journal of Cancer. 2010; 102(2) 414-8. PMID: 19997100.CR-UK C5047/A8385 CR-UK C5047/A7357

     

  10. Lophatananon A, Archer J, Easton D, Pocock R, Dearnaley D, Guy M, Kote-Jarai Z, O'Brien L, Wilkinson RA, Hall AL, Sawyer E, Page E, Liu JF, Barratt S, Rahman AA; The UK Genetic Prostate Cancer Study Collaborators; British Association of Urological Surgeons' Section of Oncology, Eeles R*, Muir K*. *Joint Senor Authors. Dietary fat and early-onset prostate cancer risk. Br J Nutr. 2010; 103(9):1375-80. PMID: 20082736.CR-UK C5047/A3354

     

  11. Whitaker HC, Kote-Jarai Z, Ross-Adams H, Warren AY, Burge J, George A, Bancroft E, Jhavar S, Leongamornlert D, Tymrakiewicz M, Saunders E, Page E, Mitra A, Mitchell G, Lindeman GJ, Evans DG, Blanco I, Mercer C, Rubinstein WS, Clowes V, Douglas F, Hodgson S, Walker L, Donaldson A, Izatt L, Dorkins H, Male A, Tucker K, Stapleton A, Lam J, Kirk J, Lilja H, Easton D; IMPACT Study Steering Committee; IMPACT Study Collaborators; UKGPCS Collaborators, Cooper C, Eeles R, Neal DE. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS One. 2010; 13;5(10):e13363. PMID: 20967219.CR-UK C5047/A8385

     

  12. Rahman AA, Lophatananon A, Stewart-Brown S, Harris D, Anderson J, Parker T, Easton D, Kote-Jarai Z, Pocock R, Dearnaley D, Guy M, O'Brien L, Wilkinson RA, Hall AL, Sawyer E, Page E, Liu JF; The UK Genetic Prostate Cancer Study Collaborators; British Association of Urological Surgeons' Section of Oncology, Eeles RA*, Muir K*. *Joint Senior Authors. Hand pattern indicates prostate cancer risk. British Journal of Cancer. 2011; 104(1):175-177.PMID: 21119657.CR-UK C5047/A8385 NIHR BRC.

     

  13. Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson BE, Isaacs WB, Benford ML, Kidd LR, Cooney K, Strom SS, Ingles SA, Stern MC, Corral R, Joshi AD, Xu J, Giri VN, Rybicki BA, Neslund-Dudas C, Kibel AS, Thompson IM Jr, Leach RJ, Ostrander EA, Stanford J, Witte JS, Casey G, Eeles R; for the UKGPCS Coordinating Group and Collaborators, Hsing AW, Chanock SJ, Hu JJ, John EM, Park JY, Stefflova K, Zeigler-Johnson C, Rebbeck TR. Validation of genome-wide prostate cancer association in men of African descent. Cancer Epidemiol Biomarkers Prev. 2011; 20(1):23-32. PMID 21071540.CR-UK C5047/A7357 NIHR BRC..

     

  14. Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Canzian F, Riboli E, Key T, Gronberg H, Hunter DJ, Kraft P, Thun MJ, Ingles S, Chanock S, Albanes D, Hayes RB, Neal DE, Hamdy FC, Donovan JL, Pharoah P, Schumacher F, Henderson BE, Standord JL Ostrander EA, Sorensen KD, Dork T, Andiole G, Dickinson JL, Cybulski C, Lubinski J, Spurdle A, Clements JA, Chambers S, Aitken J, Gardiner RAF, Thibodeau SN, Schaid D, John EM, Maier C, Vogel W, Cooney KA, Park JY, Cannon-Albright L, Brener H, Habuchi T, Zhang H-W, Lu Y-J, Kaneva R, Muir K, Benlloch S, Leongamornlert DA, Saunders EJ, Tymrakiewicz M, Mahmud N, Guy M, O’Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van AS N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English D, Wahlfors T, Tammela TLJ, Klarskov P, Nordestgaard R, Roder MA, Tybjaerg-Hansen A, Bojesen SE, Travis R, Campa D, Kaaks R, Wiklund F, Aly M, Lindstrom S, Diver WR, Gapstur S, Stern MC, Corral R, Virtamo J, Cox A, Haiman CA, Marchand LL, FitzGerald L, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Meyer A, Serth J, Yeager M, Berndt SI, Marthick JR, Patterson B, Wokolorczyk D, Batra J, Lose F, McDonnell SK, Joshi AD, Shahabi A, Rinckleb AE, Ray A, Sellers TA, Lin H-Y, Stephenson RA, Farnham J, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao G-W, Slavov C, Mitev V, The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology, The UK ProtecT Study Collaborators, The PRACTICAL Consortium, Easton DF, Eeles RA. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nature Genetics. 2011;43(8):785-91. PMID: 21743467.C5047/A7357, A3354, A10692

     

  15. Macinnis RJ, Antoniou AC, Eeles RA, Severi G, Al Olama AA, McGuffog L, Kote-Jarai Z, Guy M, O'Brien LT, Hall AL, et al.Wilkinson RA, Sawyer E, Ardern-Jones AT, Dearnaley DP, Horwich A, Khoo VS, Parker CC, Huddart RA, Van As N, McCredie MR, English DR, Giles GG, Hopper JL, Easton DF. A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact. Genet Epidemiol. 2011; 35(6):549-56. PMID: 21769933. CR-UK C5047/A3354 NIHR BRC.

     

  16. Schumacher FR, Berndt SI, Siddiq A, Jacobs KB, Wang Z, Lindstrom S, Stevens VL, Chen C, Mondul AM, Travis RC, Stram DO, Eeles RA, Easton DF, Giles G, Hopper JL, Neal DE, Hamdy FC, Donovan JL, Muir K, Al Olama AA, Kote-Jarai Z, Guy M, Severi G, Grönberg H, Isaacs WB, Karlsson R, Wiklund F, Xu J, Allen NE, Andriole GL, Barricarte A, Boeing H, Bas Bueno-de-Mesquita H, Crawford ED, Diver WR, Gonzalez CA, Gaziano JM, Giovannucci EL, Johansson M, Le Marchand L, Ma J, Sieri S, Stattin P, Stampfer MJ, Tjonneland A, Vineis P, Virtamo J, Vogel U, Weinstein SJ, Yeager M, Thun MJ, Kolonel LN, Henderson BE, Albanes D, Hayes RB, Spencer Feigelson H, Riboli E, Hunter DJ, Chanock SJ, Haiman CA, Kraft P. Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet. 2011; 20(19): 3867-75. PMID: 21743057.CR-UK C5047/A10692/A3354/A7357 NIHR BRC.

     

  17. Kote-Jarai Z, Leongamornlet D*, Saunders E*, Tymrakiewicz M, Castro E, Mahmud N, Guy M, Edwards S, O’Brien L, Sawyer E, Hall A, Wilkinson R, Tokhir D, Goh C, The UKGPCS Collaborators, Easton D, Goldgar D, Eeles R. *contributed equally to this Study. BRCA2 is a moderate penetrance gene contributing to young onset prostate cancer: implications for genetic testing in prostate cancer patients. British Journal of Cancer. 2011; 105(8):1230-4. PMID: 21952622.CR-UK C5047/A7357/A3354/A10692 & PCUK G2011/36NIHR BRC.
  18. Leongamornlert D, Mahmud N, Tymrakiewicz M, Saunders E, Dadaev T, Castro E, Goh C, Govindasami K, Guy M, O'Brien L, Sawyer E, Hall A, Wilkinson R, Easton D; The UKGPCS Collaborators, Goldgar D, Eeles R, Kote-Jarai Z. Germline BRCA1 mutations increase prostate cancer risk. British Journal of Cancer.2012;106(10):1697-701.PMID: 22516946.CR-UK C5047/A7357/A3354/A10692 & PCUK G2011/36 NIHR BRC.

     

    2013

  19. Orozco G, Goh CL, Al Olama AA, Benlloch-Garcia S, Govindasami K, Guy M, Muir KR, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Kote-Jarai Z, Easton DF, Eyre S, Eeles RA. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis. BJU Int. 2013; 111(7):1148-55. PMID: 22985493.CR-UK C5047/A10692 NIHR BRC.

     

  20. Eeles R.A, Al Olama AA., Benlloch S, Saunders E.J, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K., Giles, G.G., Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Marchand LL, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock S, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F., Riboli A, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah P, Pashayan N, Khaw K-T, StanfordJL, Ostrander EA, Signorello LB, ThibodeauSN, Schaid D, Maier C, Vogel W, Kibel SA, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle A, Clements J, Teixeira MR, Dicks E, Lee A, Dunning A, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet M, Stern A, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TLJ, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Roder MA, Nielsen SF, Bojesen SE, Siddiq A, FitzGerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb A, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin H-Y, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Vincent D, Bacot F, Tessier DC, Kote-Jarai Z, & Easton DF. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom gentotyping array. Nature Genetics. 2013; 45(4):385-91.PMID: 23535732.C5047/A7357, A3354, A10692 & PCUK G2011/36.

     

  21. Al Olama AA, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Hunter DJ, Henderson BE, Thun MJ, Gaziano M, Giovannucci EL, Siddiq A, Travis RC, Cox DG, Canzian F, Riboli E, Key TJ, Andriole G, Albanes D, Hayes RB, Schleutker J, Auvinen A, Tammela TL, Weischer M, Stanford JL, Ostrander EA, Cybulski C, Lubinski J, Thibodeau SN, Schaid DJ, Sorensen KD, Batra J, Clements JA, Chambers S, Aitken J, Gardiner RA, Maier C, Vogel W, Dörk T, Brenner H, Habuchi T, Ingles S, John EM, Dickinson JL, Cannon-Albright L, Teixeira MR, Kaneva R, Zhang HW, Lu YJ, Park JY, Cooney KA, Muir KR, Leongamornlert DA, Saunders E, Tymrakiewicz M, Mahmud N, Guy M, Govindasami K, O'Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English D, Virtamo J, Le Marchand L, Campa D, Kaaks R, Lindstrom S, Diver WR, Gapstur S, Yeager M, Cox A, Stern MC, Corral R, Aly M, Isaacs W, Adolfsson J, Xu J, Zheng SL, Wahlfors T, Taari K, Kujala P, Klarskov P, Nordestgaard BG, Røder MA, Frikke-Schmidt R, Bojesen SE, FitzGerald LM, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Rinckleb A, Luedeke M, Herkommer K, Meyer A, Serth J, Marthick JR, Patterson B, Wokolorczyk D, Spurdle A, Lose F, McDonnell SK, Joshi AD, Shahabi A, Pinto P, Santos J, Ray A, Sellers TA, Lin HY, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators; Australian Prostate Cancer Bioresource; PRACTICAL Consortium, Chanock S, Gronberg H, Haiman CA, Kraft P, Easton DF, Eeles RA. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet. 2013 ; 22(2):408-15.PMID: 23065704.CR-UK C5047/A7357/A3354/A10692.

     

  22. Goh CL, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Thomas K, Selvadurai ED, Woode-Amissah R, Dadaev T, Mahmud N, Castro E, Olmos D, Guy M, Govindasami K, O'Brien LT, Hall AL, Wilkinson RA, Sawyer EJ, Al Olama AA, Easton DF, Kote-Jarai Z, Parker CC, Eeles RA. Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort. BJU Int. 2013; 112(5):666-73. PMID: 23320731.CR-UK C5047/A8385 NIHR BRC.

     

  23. Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA, Benlloch S, Halim S, Russel R, Dunning AM, Luccarini C, Dennis J, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Marchand LL, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock S, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah P, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle A, Clements JA, Teixeira MR, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dicks E, Baynes C, Conroy D, Bojesen SE, Kaaks R, Vincent D, Bacot F, Tessier DC; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative; The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology; The UK ProtecT Study Collaborators; The PRACTICAL Consortium, Easton DF, Eeles RA. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet. 2013; 22(12):2520-8. PMID: 23535824.CR-UK C5047/A7357/A3354/A10692 NIHR BRC.

     

  24. Castro E, Goh C, Olmos D, Saunders E, Leongamornlert D, Tymrakiewicz M, Mahmud N, Dadaev T, Govindasami K, Guy M, Sawyer E, Wilkinson R, Ardern-Jones A, Ellis S, Frost D, Peock S, Evans DG, Tischkowitz M, Cole T, Davidson R, Eccles D, Brewer C, Douglas F, Porteous ME, Donaldson A, Dorkins H, Izatt L, Cook J, Hodgson S, Kennedy MJ, Side LE, Eason J, Murray A, Antoniou AC, Easton DF, Kote-Jarai Z, Eeles R. Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer. J Clin Oncol. 2013; 31(14):1748-57. PMID: 23569316.CR-UK C5047/A13232 NIHR BRC.CR-UK C5047/A14835.

     

  25. Leongamornlert D, Saunders E, Dadaev T, Tymrakiewicz M, Goh C, Jugurnauth-Little S, Kozarewa I, Fenwick K, Assiotis I, Barrowdale D, Govindasami K, Guy M, Sawyer E, Wilkinson R; UKGPCS Collaborators, Antoniou AC, Eeles R, Kote-Jarai Z. Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease. British Journal of Cancer. 2014; 110(6):1663-72. PMID: 24556621.CR-UK C5047/A15007 NIHR BRC.

     

  26. Saunders EJ, Dadaev T, Leongamornlert DA, Jugurnauth-Little S, Tymrakiewicz M, Wiklund F, Al Olama AA, Benlloch S, Neal DE, Hamdy FC, Donovan JL, Giles GG, Severi G, Gronberg H, Aly M, Haiman CA, Schumacher F, Henderson BE, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock S, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Nordestgaard BG, Canzian F, Campa D, Riboli E, Key TJ, Travis RC, Ingles SA, John EM, Hayes RB, Pharoah P, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Clements JA, Teixeira MR, Xu J, Mikropoulos C, Goh C, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF, Muir K, Eeles RA, Kote-Jarai Z. Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer. PLoS Genet. 2014; 10(2): e1004129. PMID: 24550738.

     

  27. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Stram DO, Rand K, Wan P, Stram A, Sheng X, Pooler LC, Park K, Xia L, Tyrer J, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tammela TL, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Leinonen KA, Xu J, Aly M, Donovan J, Travis RC, Key TJ, Siddiq A, Canzian F, Khaw KT, Takahashi A, Kubo M, Pharoah P, Pashayan N, Weischer M, Nordestgaard BG, Nielsen SF, Klarskov P, Røder MA, Iversen P, Thibodeau SN, McDonnell SK, Schaid DJ, Stanford JL, Kolb S, Holt S, Knudsen B, Coll AH, Gapstur SM, Diver WR, Stevens VL, Maier C, Luedeke M, Herkommer K, Rinckleb AE, Strom SS, Pettaway C, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Cannon-Albright L, Cybulski C, Wokołorczyk D, Kluźniak W, Park J, Sellers T, Lin HY, Isaacs WB, Partin AW, Brenner H, Dieffenbach AK, Stegmaier C, Chen C, Giovannucci EL, Ma J, Stampfer M, Penney KL, Mucci L, John EM, Ingles SA, Kittles RA, Murphy AB, Pandha H, Michael A, Kierzek AM, Blot W, Signorello LB, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske C, Wu SY, Hennis A, Kibel AS, Rybicki BA, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Batra J, Clements J, Spurdle A, Teixeira MR, Paulo P, Maia S, Slavov C, Kaneva R, Mitev V, Witte JS, Casey G, Gillanders EM, Seminara D, Riboli E, Hamdy FC, Coetzee GA, Li Q, Freedman ML, Hunter DJ, Muir K, Gronberg H, Neal DE, Southey M, Giles GG, Severi G; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; COGS (Collaborative Oncological Gene-environment Study) Consortium; GAME-ON/ELLIPSE Consortium, Cook MB, Nakagawa H, Wiklund F, Kraft P, Chanock SJ, Henderson BE, Easton DF, Eeles RA, Haiman CA. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nature Genetics. 2014;46(10):1103-9. PMID: 25217961. C5047/A10692/A8384/A15007 NIHR BRC EURO FP7 223175 PCUK G2011/36&G2012/48.

     

    2015

  28. Kote-Jarai Z, Mikropoulos C, Leongamornlert DA, Dadaev T, Tymrakiewicz M, Saunders EJ, Jones M, Jugurnauth-Little S, Govindasami K, Guy M, Hamdy FC, Donovan JL, Neal DE, Lane JA, Dearnaley D, Wilkinson RA, Sawyer EJ, Morgan A; The UK Genetic Prostate Cancer Study Collaborators; the ProtecT Study Group, Antoniou AC, Eeles RA. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes. Ann Oncol. 2015;26(4):756-61.PMID: 25595936.NIHR BRC.

     

  29. Al Olama AA, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, Aly M, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokozorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Butterbach K, Arndt V, Park JY, Sellers T, Lim HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Govindasami K, Guy M, Muir K, Viñuela A, Brown AA; PRACTICAL Consortium; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative; Australian Prostate Cancer BioResource; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators, Freedman M, Conti DV, Easton D, Coetzee GA, Eeles RA, Kote-Jarai Z.Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Hum Mol Genet. 2015; 24(19):5589-602.PMID:26025378. CR-UK C5047/A7357/A3354/10692.

     

  30. Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman CA, Schumacher FR, Pashayan N, Pharoah PD, Ostrander EA, Stanford JL, Batra J, Clements JA, Chambers SK, Weischer M, Nordestgaard BG, Ingles SA, Sorensen KD, Orntoft TF, Park JY, Cybulski C, Maier C, Doerk T, Dickinson JL, Cannon-Albright L, Brenner H, Rebbeck TR, Zeigler-Johnson C, Habuchi T, Thibodeau SN, Cooney KA, Chappuis PO, Hutter P, Kaneva RP, Foulkes WD, Zeegers MP, Lu YJ, Zhang HW, Stephenson R, Cox A, Southey MC, Spurdle AB, FitzGerald L, Leongamornlert D, Saunders E, Tymrakiewicz M, Guy M, Dadaev T, Little SJ, Govindasami K, Sawyer E, Wilkinson R, Herkommer K, Hopper JL, Lophatonanon A, Rinckleb AE, Kote-Jarai Z, Eeles RA, Easton DF; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators; PRACTICAL Consortium. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.Cancer Epidemiol Biomarkers Prev. 2015;24(7):1121-9.PMID: 25837820.CR-UK C5047/A10692.

     

  31. Castro E, Jugurnauth-Little S, Karlsson Q, Al-Shahrour F, Piñeiro-Yañez E, Van de Poll F, Leongamornlert D, Dadaev T, Govindasami K, Guy M, Eeles R, Kote-Jarai Z; UKGPCS, EMBRACE and IMPACT studies. High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers. Ann Oncol. 2015; 26(11):2293-300.PMID: 26347108.  

    2016

  32. Saunders EJ, Dadaev T, Leongamornlert DA, Olama AA, Benlloch S, Giles GG,, Wiklund F, Grönberg H, Haiman CA, Schleutker J,, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR,, Pandha H, Govindasami K, Muir K; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF, Eeles RA, Kote-Jarai Z. Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. British Journal of Cancer. 2016; 114(8): 945-52.PMID: 26964030.CRUK C5047/A17528.

     

  33. MacInnis RJ,, Schmidt DF, Makalic E, Severi G,,, FitzGerald LM, Reumann M,, Kapuscinski MK, Kowalczyk A,,Zhou Z, Goudey B, Qian G, Bui QM, Park DJ,, Freeman A, Southey MC, Al Olama AA, Kote-Jarai Z, Eeles RA, Hopper JL,, Giles GG,; UK Genetic Prostate Cancer Study Collaborators. Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2016; 25(12):1619-1624.PMID: 27539266.C5047/A3354/A7357/A10692 NIHR BRC.

     

    2018

  34. Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund F, Grönberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Govindasami K, Muir K; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF, Eeles RA, Kote-Jarai Z. Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. British Journal of Cancer.2018 Mar 20;118(6):e9 PMID: 29438362.

     

  35. FitzGerald LM, Zhao S, Leonardson A, Geybels MS, Kolb S, Lin DW, Wright JL, Eeles R, Kote-Jarai Z, Govindasami K, Giles GG, Southey MC, Schleutker J, Tammela TL, Sipeky C, Penney KL, Stampfer MJ, Gronberg H, Wiklund F, Stattin P, Hugosson J, Karyadi DM, Ostrander EA, Feng Z, Stanford JL. Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases. Prostate Cancer Prostatic Dis. 2018 Jun;21(2):228-237 PMID: 29298992.

     

  36. Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders E J, Dadaev T, Leongamornlert D,Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J,Tyrer J, Muir K, Lophatananon A, Stevens V L, Gapstur SM, Carter BD, Tangen, Catherine M,Goodman P J, Thompson IM, Batra J, Chambers S, Moya Lire, Clements J, Horvath L, Tilley W,Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, TammelaTLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West, CML, Dunning, AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cusseno, O, Cancel-Tassin G, Koutros S,Beane FLE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal, Eli Marie, Neal DE, Donovan,JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald, LM, Kibel AS, Drake BF, Vega A, Gómez-Camaño,A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park,JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk,K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR,Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S,Townsend PA, Aukim-Hastie C, Dominguez MG, Castelao JE, Martinez ME, Roobol MJ, Jenster G,van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ,Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft,P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature Genetics. 2018;50(7):928-936.. PMID 29892016.

     

    2019

  37. Mijuskovic M, Saunders EJ, Leongamornlert DA, Wakerell S, Whitmore I, Dadaev T, Cieza-Borrella C, Govindasami K, Brook MN, Haiman CA, Conti DV, Eeles RA, Kote-Jarai Z. Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease. British Journal of Cancer. 2019 Apr;120(8):867. PMID: 30837682.

     

    2020

  38. Karunamuni RA, Huynh-Le MP, Fan CC, Thompson W, Eeles R , Kote-Jarai Z, Muir K, UKGPCS Collaborators; Lophatananon A , Tangen CM, Goodman PJ,Thompson Jr IM, Blot WJ, Zheng W, Kibel AS, Drake BF, Cussenot O, Cancel-Tassin G, Menegaux F, Truong T, Park JY, Lin HY, Bensen JT, Fontham ETH, Mohler JL, Taylor JA ,Multigner L, Blanchet P, Brureau L, Romana M, Leach RJ, John EM, Fowke J, Bush WS, Aldrich M, Crawford DC, Srivastava S, Cullen JC, Petrovics G, Parent M, Hu JJ, Sanderson M, Mills IG, Andreassen OA, Dale AM, Seibert TM, PRACTICAL Consortium. African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer. 2020 Sep 15. PMID: 32930425. C5047/A10692/A3354/A7357/A15007/A8384Int J Cancer. 2021 January 01.

     

  39. Aladwani M, Lophatananon A, Robinson F, Rahman A, Ollier W, Kote-Jarai Z, Dearnaley D, Govindasami K, Hussain N, Rageevakumar R, Keating D, Osborne A, Dadaev T, Brook M, British Association of Urological Surgeons’ Section of Oncology; Eeles R, Muir KR. Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study. 2020 May 22. PMID: 32941451 CRUK C5047/A8385 NIHR BRCPLoS One.

     

  40. Brandão A, Paulo P, Maia S, Pinheiro M, Peixoto A, Cardoso M, Silva MP, Santos C,  Eeles R, Kote-Jarai Z, Muir K, UKGPCS Collaborators, Schleutker J, Wang Y, Pashayan N, Batra NJ, Apcb BioResource, Grönberg H, Neal DE, Nordestgaard BG, Tangen CM, Southey MC, Wolk A, Albanes D, Haiman CA, Travis RC, Stanford JL, Mucci LA, West CML, Nielsen SF, Kibel AS, Cussenot O, Berndt SI, Koutros S, Sørensen KD, Cybulski C, Grindedal EM, Park JY, Ingles SA, Maier C, Hamilton RJ, Rosenstein BS, Vega A, The Impact Study Steering Committee And Collaborators, Kogevinas M, Wiklund F, Penney KL, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, Ruyck KD, Razack A, Newcomb LF, Canary Pass Investigators, Lessel D, Usmani , The Practical Consortium, Teixeira MR.The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor.2020 Nov 4. PMID: 33158149.CRUK C5047/A7357/A3354/A10692 NIHR BRCCancers (Basel).

     

  41. Karunamuni RA, Huynh-Le MP, Fan CC, Thompson W, Eeles R, Kote-Jarai Z, Muir K, UKGPCS Collaborators; Lophatananon A, Tangen CM, Goodman PJ, Thompson Jr IM, Blot WJ, Zheng W, Kibel AS, Drake BF, Cussenot O, Cancel-Tassin G, Menegaux F, Truong T, Park JY, Lin H, Bensen JT, Fontham ETH, Mohler JL, Taylor JA, Multigner L, Blanchet P, Brureau L, Romana M, Leach RJ, John EM, Fowke J, Bush WS, Aldrich M, Crawford DC, Srivastava S, Cullen JC, Petrovics G, Parent ME, Hu JJ, Sanderson M, Mills IG,  Andreassen OA, Dale AM, Seibert TM, PRACTICAL Consortium. African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer in International Journal of Cancer (Published in issue).2020 Sep15. PMID: 32930425.CRUK C5047/A7357/A3354/A10692 NIHR BRCInt J Cancer.

     

    2021

  42. Karunamuni RA, Huynh-Le MP, Fan CC, Thompson W, Eeles RA, Kote-Jarai Z, Muir K, Lophatananon A, UKGPCS collaborators; Schleutker J, Pashayan N, Batra J, APCB BioResource (Australian Prostate Cancer BioResource); Grönberg H, Walsh EI, Turner EL, Lane A, Martin RM, Neal DE, Donovan JL, Hamdy FC,Nordestgaard BG, Tangen CM, MacInnis RJ, Wolk A, Albanes D, Haiman CA, Travis RC, Stanford JL, Mucci LA, West CML, Nielsen SF, Kibel AS, Wiklund F, Cussenot O, Berndt SI, Koutros S, Sørensen KD, Cybulski C,Grindedal EM, Park JY, Ingles SA, Maier C, Hamilton RJ, Rosenstein BS, Vega A, IMPACT Study Steering Committee and Collaborators; Kogevinas M, Penney KL, Teixeira MR, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, Razack A, Newcomb LF, Canary PASS Investigators; Gamulin M, Usmani N, Claessens F, Gago-Dominguez M, Townsend PA, Roobol MJ, Zheng W, Profile Study Steering Committee; Mills IG, Andreassen OA, Dale AM, Seibert TM, PRACTICAL Consortium. Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer. 2021 Jan 8. PMID: 33420416 Prostate Cancer Prostatic Dis.

     

  43. Lin H, Huang P, Cheng C, Tung H, Fang Z, Berglund AE, Chen A, French-Kwawu JF, Harris D, Pow-Sang J, Yamoah K, Cleveland JL, Awasthi S, Rounbehler RJ , Gerke T, Dhillon J, Eeles R, Kote-Jarai Z, Muir K, UKGPCS collaborators; Schleutker J, Pashayan N, APCB (Australian Prostate Cancer BioResource); Neal DE, Nielsen SF, Nordestgaard BG, Gronberg H, Wiklund F, Giles GG, Haiman CA, Travis RC, Stanford JL, Kibel AS, Cybulski C, Khaw K, Maier C, Thibodeau SN, Teixeira MR, Cannon-Albright L, Brenner H, Radka Kaneva, Pandha H, PRACTICAL consortium; Srinivasan S, Clements J, Batra J, Park JY.KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.2021 Apr 29. PMID: 33927218. Scientific reports.

     

  44. Huynh-Le MP, Fan CC, Karunamuni R, Thompson WK, Martinez ME, Eeles RA, Kote-Jarai Z, Muir K, Schleutker J, Pashayan N, Batra J, Grönberg H, Neal DE, Donovan JL, Hamdy FC, Martin RM, Nielsen SF, Nordestgaard BG, Wiklund F, Tangen CM, Giles G, Wolk A, Albanes D, Travis RC, Blot WJ, Zheng W, Sanderson M, Stanford JL, Mucci LA, West CML, Kibel AS, Cussenot O, Berndt SI, Koutros S, Sørensen KD, Cybulski C, Grindedal EM, Menegaux F, Khaw KT, Park JY, Ingles SA, Maier C, Hamilton RJ, Thibodeau SN, Rosenstein BS, Lu YJ, Watya S, Vega A, Kogevinas M, Penney KL, Huff C, Teixeira MR, Multigner L, Leach RJ, Cannon-Albright L, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, Ruyck KD, Pandha H, Razack A, Newcomb LF, Fowke JH, Gamulin M, Usmani N, Claessens F, Gago-Dominguez M, Townsend PA, Bush WS, Roobol MJ, Parent ME, Hu JJ, Mills IG, Andreassen OA, Dale AM, Seibert TM, UKGPCS collaborators; APCB (Australian Prostate Cancer BioResource); NC-LA PCaP Investigators; IMPACT Study Steering Committee and Collaborators; Canary PASS Investigators; Profile Study Steering Committee; PRACTICAL Consortium. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations. 2021 Feb 23. PMID: 33623038 Nature Communications.

     

  45. Karunamuni RA, Huynh-Le M, Fan CC, Thompson W, Lui A, Martinez ME, Rose BS, Mahal B, Eeles RA, Kote-Jarai Z, Muir K, Lophatananon A, UKGPCS Collaborators; Tangen CM, Goodman PJ, Thompson Jr IM, Blot WJ, Zheng W, Kibel AS, Drake BF, Cussenot O, Cancel-Tassin G, Menegaux F, Truong T, Park JY, Lin H, Taylor JA, Bensen JT, Mohler JL, Fontham ETH, Multigner L, Blanchet P, Brureau L, Romana M, Leach TJ, John EM, Fowke JH, Bush WS, Aldrich MC, Crawford DC, Cullen J, Petrovics G, Parent M, Hu JJ, Sanderson M, PRACTICAL Consortium; Mills IG, Andreassen OA, Dale AM, Seibert TM. Prostate cancer risk stratification with an African-specific polygenic hazard score varies with local ancestry in 8q24. 2021 Jun 14. PMID: 34127801 Nature Genetics.

     

  46. Salmon C, Song L, Muir K, UKGPCS Collaborators; Pashayan N, Dunning AM, Batra J, APCB BioResource (Australian Prostate Cancer BioResource); Chambers S, Stanford JL, Ostrander EA, Jong Y Park, Hui-Yi Lin, Cussenot O, Cancel-Tassin G, Menegaux F, Cordina-Duverger E, Kogevinas M,  Llorca J, Kaneva R, Slavov C, Razack A, Lim J, Gago-Dominguez M, Castelao JE, Kote-Jarai Z, Eeles RA, on behalf of the PRACTICAL Consortium; Marie-Élise Parent. Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortium. 2021 Jul 18. PMID: 34275018 Eur J Epidemiol.

     

  47. Huynh-Le M, Karunamuni R, Fan CC, Asona L, Thompson WK, Martinez ME, Eeles R, Kote-Jarai Z, Muir KR, Lophatananon A, Schleutker J, Pashayan N, Batra J, Grönberg H, Neal DE, Nordestgaard BG, Tangen CM, MacInnis RJ, Wolk A, Albanes D, Haiman CA, Travis RC, Blot WJ, Stanford JL, Mucci LA, West CML, Nielsen SF, Kibel AS, Cussenot O, Berndt SI,Koutros S, Sørensen KD, Cybulski C, Grindedal EM, Menegaux F, Park JY, Ingles SA, Maier C, Hamilton RJ, Rosenstein BS, Lu Y, Watya S, Vega A, Kogevinas M, Wiklund F, Penney KL, Huff CD, Teixeira MR, Multigner L, Leach RJ, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, Ruyck KD, Ost P, Razack A, Newcomb LF, Fowke JH, Gamulin M, Abraham A,Claessens F, Castelao JE, Townsend PA, Crawford DC, Petrovics G, Schaik RHNV, Parent M, Hu JJ, Zheng W, UKGPCS collaborators; APCB (Australian Prostate Cancer BioResource); NC-LA PCaP Investigators; IMPACT Study Steering Committee and Collaborators; Canary PASS Investigators; Profile Study Steering Committee; PRACTICAL Consortium; Mills IG ,Andreassen OA, Dale AM, Seibert TM. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score. Feb 2022.PMID: 35152271, Nature Genetics.

     

    2022

  48. Darst BF, Hughley R, Pfennig A, Hazra U, Fan C, Wan P, Sheng X, Xia L, Andrews C, Chen F, Berndt SI, Kote-Jarai Z, Govindasami K, Bensen JT, Ingles SA, Rybicki BA, Nemesure B, John EM, Fowke JH, Huff CD, Strom SS, Isaacs WB, Park JY, Zheng W, Ostrander EA, Walsh PC , Carpten J, Sellers TA, Yamoah K, Murphy AB, Sanderson M, Crawford DC, Gapstur SM, Bush WS, Aldrich MC, Cussenot O, Petrovics G, Cullen J, Neslund-Dudas C, Kittles RA, Xu J, Stern MC, Chokkalingam AP, Multigner L, Parent M, Menegaux F, Cancel-Tassin G, Kibel AS, Klein EA, Goodman PJ, Stanford JL, Drake BF, Hu JJ, Clark PE, Blanchet P, Casey G, Hennis AJM, Lubwama A, Thompson Jr IM, Leach RJ, SM, Pooler L, Mohler JL, Fontham ETH, Smith GJ, Taylor JA, Brureau L, Blot WJ, Biritwum R, Tay E, Truelove A, Niwa S, Tettey Y, Varma R, McKean-Cowdin R, Torres M, Jalloh M, Gueye SM, Niang L,Ogunbiyi O, Idowu MO, Popoola O, Adebiyi AO, Aisuodionoe-Shadrach AI, Nwegbu M, Adusei B, Mante S, Darkwa-Abrahams A, Yeboah ED, Mensah JE, Adjei AA, Diop H, Cook MB, Chanock SJ, Watya S, Eeles R, Chiang CWK,Lachance J, Rebbeck TR, Conti DV, Haiman CA. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.2022 Jan.PMID: 35031163 DOI: 10.1016/j. European Urology.2021.12.023.

     

  49. Gregg J, Kim J, Logothetis C, Hanash S, Zhang X, Manyam G, Muir K, UK Genetic Prostate Cancer Study collaborators, Giles G, Stanford J, Berndt S, Kogevinas M, Brenner H, Eeles R, PRACTICAL CONSORTIUM, Wei P, and Daniel C. Coffee intake, caffeine metabolism genotype, and survival in men with prostate cancer.2023 Jun;6(3):282-288. doi: 10.1016/j.European Urology.2022.07.008. PMID: 35995710.

     

  50. Brook M, Raghallaigh HN, Govindasami K, Dadaev T, Rageevakuma R, KeatingD, Hussain N, Osborne A,Lophatananon A, UKGPCS collaborators, Muir K, Kote-Jarai Z, Eeles R. Family History of Prostate Cancer and Survival Outcomes in the United Kingdom Genetic Prostate Cancer Study.2022. 2023 Mar;83(3):257-266. doi: 10.1016/j.eururo.2022.11.019.PMID: 36528478European Urology.

     

    2023

  51. Tommy Nyberg, PhD,corresponding author 1 , 2 Mark N. Brook, PhD, 3 Lorenzo Ficorella, PhD, 1 Andrew Lee, PhD, 1 Joe Dennis, MSc, 1 Xin Yang, PhD, 1 Naomi Wilcox, MSc, 1 Tokhir Dadaev, MSc, 3 Koveela Govindasami, MSc, 3 Michael Lush, PhD, 1 Goska Leslie, MEng, 1 Artitaya Lophatananon, PhD, 4 Kenneth Muir, PhD, 4 Elizabeth Bancroft, RN, 3 , 5 Douglas F. Easton, PhD, 1 Marc Tischkowitz, PhD, 6 Zsofia Kote-Jarai, PhD, 3 Rosalind Eeles, PhD, 3 , 5 and Antonis C. Antoniou, PhD . CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer. J Clin Oncol. 2023 Feb 10; 41(5): 1092–1104. Published online 2022 Dec 9. doi: 10.1200/JCO.22.01453.
  52. Anqi Wang, Jiayi Shen, Alex A. Rodriguez, Edward J. Saunders, Fei Chen, Rohini Janivara, Burcu F. Darst, et.al, Rosalind A. Eeles, Zsofia Kote-Jarai, Ravi K. Madduri, David V. Conti & Christopher A. Haiman. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nature Genetics. doi: 10.1038/s41588-023-01534-4. Epub 2023 Nov 9.